SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,271,166 | +4.6% | 307,487 | +0.7% | 0.02% | 0.0% |
| Q2 2023 | $34,665,634 | +18.3% | 305,451 | +43.3% | 0.02% | +12.5% |
| Q1 2023 | $29,314,176 | +847.2% | 213,132 | +727.3% | 0.02% | +700.0% |
| Q4 2022 | $3,094,909 | +1063.5% | 25,763 | +971.7% | 0.00% | – |
| Q3 2022 | $266,000 | +34.3% | 2,404 | 0.0% | 0.00% | – |
| Q2 2022 | $198,000 | -7.0% | 2,404 | 0.0% | 0.00% | – |
| Q1 2022 | $213,000 | +22.4% | 2,404 | 0.0% | 0.00% | – |
| Q4 2021 | $174,000 | -21.6% | 2,404 | 0.0% | 0.00% | – |
| Q3 2021 | $222,000 | -83.3% | 2,404 | -85.9% | 0.00% | -100.0% |
| Q2 2021 | $1,328,000 | – | 17,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |